Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0-2 Months old Low Birth Weight Infants in India | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0-2 Months old Low Birth Weight Infants in India

Implementing Organization

Principal Investigator

Dr Anju Pradhan Sinha

Scientist

|

Indian Council of Medical Research (ICMR), New Delhi

Abstract

NA

Patents

NA

Achievements

NA

Outcome / Output

NA

Publications

NA

Related Research

Funding Organization

Funding Organization

Medical Research Council (MRC), UK

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Child Health

Start Year

2019

End Year

2022

Sanction Amount

₹ 20.51 Cr

Status

Completed

Contact

sinhaa.hq@icmr.gov.in

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

NA

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…